Cargando…
The unfavorable effects of COVID‐19 on Dutch advanced melanoma care
The COVID‐19 pandemic had a severe impact on medical care. Our study aims to investigate the impact of COVID‐19 on advanced melanoma care in the Netherlands. We selected patients diagnosed with irresectable stage IIIc and IV melanoma during the first and second COVID‐19 wave and compared them with p...
Autores principales: | van Not, Olivier J., van Breeschoten, Jesper, van den Eertwegh, Alfonsus J. M., Hilarius, Doranne L., De Meza, Melissa M., Haanen, John B., Blank, Christian U., Aarts, Maureen J. B., van den Berkmortel, Franchette W. P. J., de Groot, Jan Willem B., Hospers, Geke A. P., Ismail, Rawa K., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S., Stevense‐den Boer, Marion A. M., van der Veldt, Astrid A. M., Vreugdenhil, Gerard, Boers‐Sonderen, Marye J., Blokx, Willeke A. M., Suijkerbuijk, Karijn P. M., Wouters, Michel W. J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652896/ https://www.ncbi.nlm.nih.gov/pubmed/34605003 http://dx.doi.org/10.1002/ijc.33833 |
Ejemplares similares
-
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands
por: van Breeschoten, Jesper, et al.
Publicado: (2021) -
Real‐world outcomes of advanced melanoma patients not represented in phase III trials
por: van Zeijl, Michiel C. T., et al.
Publicado: (2020) -
Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases
por: Ismail, Rawa K., et al.
Publicado: (2020) -
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis
por: De Meza, Melissa M., et al.
Publicado: (2023) -
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
por: van Not, Olivier J., et al.
Publicado: (2023)